At Inke S.A. we are dedicated to the development and manufacture of high-quality APIs, specializing in complex synthesis processes, particularly for respiratory therapies.

With over 25 years of experience in micronization and based in Barcelona, Spain, Inke has been at the forefront of pharmaceutical innovation since 1980. We are a trusted partner in the global pharmaceutical industry, supplying APIs to markets across Europe, the US, Japan, and more. Our commitment to quality and regulatory excellence is reflected in our successful inspections by major global authorities, including the US-FDA, with our most recent inspection in April 2019.

Our portfolio reflects our deep commitment to innovation, patent leadership, and scientific excellence in the pharmaceutical field. We develop, patent, and implement own synthesis routes, ensuring compliance with stringent regulatory requirements and delivering tailor-made solutions for our customers.

In addition to our micronization expertise, we provide comprehensive support for the regulatory process, including Drug Master Files (DMFs), Certificates of Suitability (CEPs), and full technical assistance. Our R&D initiatives and advanced laboratory facilities make us a leading player in the respiratory therapeutics space, always pushing boundaries to meet customer and patient needs.